Development Status

The drugs and devices from our portfolio companies follow a clear development path from discovery to approval.

Current Therapeutics Development Status

Discovery
Pre-Ind
IND
Phase 1
Phase 2
Phase 3
Actuate 9-ING-41
Azitra ATR-04
Azitra ATR-02
Azitra ATR-01
Azitra ATR-03
Azitra ATR-05
Cognition Therapeutics CT-1812
Encore Vision EV-06
Immusoft MPSI
Immusoft MPSII
Incysus ICY-100
Incysus ICY-200
Lantern Pharma Tavocept
Lantern Pharma Irofluven
Lantern Pharma LP-184
Lung Therapeutics LTI-01
Lung Therapeutics LTI-03
Lung Therapeutics LTI-05
Stream Therapeutics PDV
Trefoil Therapeutics TTHX1114

Current Devices Development Status

Development
FDA Approval
Commercial
Abilitech Abilitech Exo
410 Medical Lifeflow with fluids
410 Medical Lifeflow with blood
Top